Use of Eculizumab in Transplant-Associated Thrombotic Microangiopathy in a Patient With Polycystic Kidney Disease Immediately Post–Kidney Transplant: A Case Report

Transplant-associated thrombotic microangiopathy (TMA) in the post–organ transplantation setting occurs from a number of potential inciting factors, such as the use of calcineurin inhibitors, ischemic injury, infections, or antibody-mediated rejection leading to unchecked complement activation and e...

Descripción completa

Detalles Bibliográficos
Autores principales: Godara, Amandeep, Migliozzi, Daniel R., Pilichowska, Monika, Goyal, Nitender, Varga, Cindy, Gordon, Craig E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568057/
https://www.ncbi.nlm.nih.gov/pubmed/33089142
http://dx.doi.org/10.1016/j.xkme.2020.06.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568057/
https://www.ncbi.nlm.nih.gov/pubmed/33089142
http://dx.doi.org/10.1016/j.xkme.2020.06.007

Ejemplares similares